Heparin Overdose Kills 2-Year Old Transplant Survivor

A two-year-old girl appears to have died of a heparin overdose in an Omaha hospital after being admitted to treat an infection.  This tragedy is the latest in a string of infant overdoses involving the blood thinner.

Almariah Duque, a 23 month old girl from Dallas, was born with a birth defect and had survived a transplant of her small intestines, pancreas and liver in December, according to a CNN report. However, despite surviving the surgeries, Duque died at the Nebraska Medical Center on Wednesday after being given too strong a dose of the blood thinner Heparin.

Duque was given the drug, an anticoagulant, to prevent blood clotting. The hospital has apologized to Duque’s parents, and have agreed to pay medical and funeral expenses.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The little girl’s death, which is still under investigation by hospital officials, is one of a number of incidents in recent years where infants overdosed on heparin due to preventable human errors.

In October 2006, three premature infants died from a fatal heparin overdose at Methodist Hospital in Indianapolis, when the hospital used adult dosage vials of Baxter heparin instead of pediatric dosage vials. Following that incident, Baxter Healthcare Corp. sent a warning letter to healthcare workers stressing that they should read labels on the heparin vials with care to prevent such mistakes.

Another similar medication mistake was made in November 2007 at Cedars-Sinai Medical Center in Los Angeles, where babies were given the adult doses of the blood thinner, instead of the pediatric version. Although Baxter had agreed prior to this incident to change the labels for their pediatric heparin to avoid confusion, they did not issue a heparin recall for the existing stock of the drug that remained with hospitals.

Actor Dennis Quaid’s newborn twins were among the babies that were given 1,000 times the normal dosage. Quaid later filed a product liability lawsuit against Baxter, the makers of heparin, alleging that the product was unreasonably dangerous because the company packaged adult and pediatric versions of the blood thinner in vials of the same size, with nearly identical blue backgrounds, making it difficult to tell them apart.

In July 2008, 14 premature babies at a Texas hospital were given incorrect heparin doses, resulting in several deaths. That incident was attributed to a pharmacy dosing error, which resulted in babies in the neonatal intensive care unit being given much higher concentrations of blood thinner than they were prescribed.

1 Comments

  • StretchAugust 21, 2011 at 12:48 am

    Grade A stuff. I'm unquestonaibly in your debt.

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns
Zimmer Biomet CPT Hip System Linked to Increased Risk of Thigh Bone Fractures, FDA Warns (Posted today)

The FDA has issued a safety communication warning that Zimmer Biomet CPT hip system femoral stems may increase the risk of femur fractures, calling for doctors to avoid its use when possible.

Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference
Change Healthcare Data Breach Lawyers Meeting Today With MDL Judge For Initial Status Conference (Posted yesterday)

The judge presiding over all Change Healthcare lawsuits filed in federal court is holding the first status conference of the litigation, which is expected to grow significantly as Change Healthcare data breach letters continue to be sent to impacted customers.

Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury
Angiodynamics LifePort Lawsuit Filed Over Risk of the Port Catheters Failing, Causing Severe Injury (Posted 2 days ago)

Complaint comes as a panel of federal judges are scheduled to hear oral arguments later this month, to determine whether all AngioDynamics port catheter lawsuits filed in U.S. District Courts nationwide should be centralized before one judge.